Emma Di Carlo
0000-0001-7778-1042
Publication & Citation Trends
Publications
0 total
OC.09.2 THE EXTRACELLULAR MATRIX PROTEIN EMILIN2 AS A REGULATOR OF THE MYELOID RESPONSE IN A MODEL OF INFLAMMATION-INDUCED COLON CARCINOGENESIS
Cited by 0
Semantic Scholar
Interleukin-30: A novel microenvironmental hallmark of prostate cancer progression. OA
Cited by 9
Semantic Scholar
Retraction. The IL-12Rβ2 gene functions as a tumor suppressor in human B cell malignancies. OA
Cited by 0
Semantic Scholar
LymphSecondary Lymphoid Organs via Afferent Neoplastic Solid Tissues and Recirculate to NK Cells Are Abundant in Both Healthy and Noncytotoxic Human low Perforin bright CD56
Cited by 0
Semantic Scholar
OC.16.2 EMILIN2 DEFICIENCY PROMOTES TUMOR GROWTH IN AN INDUCED INFLAMMATORY MODEL OF COLON CARCINOGENESIS OA
Cited by 0
Semantic Scholar
Restricted Antigen - Impairs HLA Class I Organs Attracts Myeloid Dendritic Cells and IL-27 in Human Secondary Lymphoid
Cited by 0
Semantic Scholar
EphA3 As a Molecular Target In Multiple Myeloma: Opportunity For a Novel Therapeutic Approach With a Specific Monoclonal Antibody
Cited by 1
Semantic Scholar
Complementary IL-23 and IL-27 anti-tumor activities cause strong inhibition of human follicular and diffuse large B-cell lymphoma growth in vivo OA
Cited by 46
Semantic Scholar
Research Topics
Immunotherapy and Immune Responses
(62)
Immune Cell Function and Interaction
(42)
Cancer Immunotherapy and Biomarkers
(32)
Cytokine Signaling Pathways and Interactions
(29)
Virus-based gene therapy research
(24)
Affiliations
University of Parma
Vita-Salute San Raffaele University
Istituto Superiore di Sanità
Istituto Giannina Gaslini
San Raffaele University of Rome